Alain H. Curaudeau
Plus aucun poste en cours
Profil
Alain H.
Curaudeau joined QLT, Inc. in 2000 as Vice President of Project Planning and Management and was promoted to Senior Vice President of Project Planning and Management in July 2001.
He spent more than 15 years with Rhone-Poulenc Rorer, where he held various senior positions in project management.
Prior to joining QLT, he was Head of Project Management for aventis.
Mr. Curaudeau received Bachelor's and Master's degrees in Pharmacy from the University of Chatenay-Malabry, Paris, France and is a graduate of the Toxicology and Pharmacokinetics Programs from the same university.
He received academic training in Toxicological Pathology from the National Veterinary School in Toulouse, France.
Anciens postes connus de Alain H. Curaudeau
| Sociétés | Poste | Fin |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 29/02/2008 |
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |